Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study

Objectives: It is hypothesized that immune factors influence addictive behaviors and contribute to relapse. The primary study objectives were to: 1) compare neuropsychiatric symptoms across adults with active methamphetamine dependence, in early remission from methamphetamine dependence, and with n...

Full description

Bibliographic Details
Main Authors: Marilyn eHuckans, Bret E. Fuller, Alison L. N. Chalker, Madeleine eAdams, Jennifer M. Loftis
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-12-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fpsyt.2015.00178/full
_version_ 1798045915500511232
author Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Bret E. Fuller
Bret E. Fuller
Alison L. N. Chalker
Madeleine eAdams
Jennifer M. Loftis
Jennifer M. Loftis
Jennifer M. Loftis
author_facet Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Bret E. Fuller
Bret E. Fuller
Alison L. N. Chalker
Madeleine eAdams
Jennifer M. Loftis
Jennifer M. Loftis
Jennifer M. Loftis
author_sort Marilyn eHuckans
collection DOAJ
description Objectives: It is hypothesized that immune factors influence addictive behaviors and contribute to relapse. The primary study objectives were to: 1) compare neuropsychiatric symptoms across adults with active methamphetamine dependence, in early remission from methamphetamine dependence, and with no history of substance dependence, 2) determine whether active or recent methamphetamine dependence affects the expression of immune factors, and 3) evaluate the association between immune factor levels and neuropsychiatric symptoms. Methods: A cross-sectional study was conducted using between group comparisons and regression analyses to investigate associations among variables. Eighty-four adults were recruited into control (n = 31), methamphetamine (MA)-active (n = 17), or MA-remission (n = 36) groups. Participants completed self-report measures of anxiety, depression, and memory complaints and objective tests of attention and executive function. Blood samples were collected, and a panel of immune factors was measured using multiplex technology. Results: Relative to controls, MA dependent adults evidenced greater anxiety and depression during active use (p < 0.001) and remission (p < 0.007), and more attention, memory, and executive problems during remission (p < 0.01) but not active dependence. Regression analyses identified 10 immune factors (putatively associated with cytokine-cytokine receptor interactions) associated with anxiety, depression, and memory problems. Conclusion: While psychiatric symptoms are present during active methamphetamine dependence and remission, at least some cognitive difficulties emerge only during remission. Altered expression of a network of immune factors contributes to neuropsychiatric symptom severity.
first_indexed 2024-04-11T23:29:56Z
format Article
id doaj.art-659902ab98184e10b3d01664d7cf3c54
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-11T23:29:56Z
publishDate 2015-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-659902ab98184e10b3d01664d7cf3c542022-12-22T03:57:11ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402015-12-01610.3389/fpsyt.2015.00178167891Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array studyMarilyn eHuckans0Marilyn eHuckans1Marilyn eHuckans2Marilyn eHuckans3Bret E. Fuller4Bret E. Fuller5Alison L. N. Chalker6Madeleine eAdams7Jennifer M. Loftis8Jennifer M. Loftis9Jennifer M. Loftis10VA Portland Health Care SystemVA Portland Health Care SystemOregon Health &amp; Science UniversityMethamphetamine Abuse Research CenterVA Portland Health Care SystemVA Portland Health Care SystemVA Portland Health Care SystemVA Portland Health Care SystemVA Portland Health Care SystemOregon Health &amp; Science UniversityMethamphetamine Abuse Research CenterObjectives: It is hypothesized that immune factors influence addictive behaviors and contribute to relapse. The primary study objectives were to: 1) compare neuropsychiatric symptoms across adults with active methamphetamine dependence, in early remission from methamphetamine dependence, and with no history of substance dependence, 2) determine whether active or recent methamphetamine dependence affects the expression of immune factors, and 3) evaluate the association between immune factor levels and neuropsychiatric symptoms. Methods: A cross-sectional study was conducted using between group comparisons and regression analyses to investigate associations among variables. Eighty-four adults were recruited into control (n = 31), methamphetamine (MA)-active (n = 17), or MA-remission (n = 36) groups. Participants completed self-report measures of anxiety, depression, and memory complaints and objective tests of attention and executive function. Blood samples were collected, and a panel of immune factors was measured using multiplex technology. Results: Relative to controls, MA dependent adults evidenced greater anxiety and depression during active use (p < 0.001) and remission (p < 0.007), and more attention, memory, and executive problems during remission (p < 0.01) but not active dependence. Regression analyses identified 10 immune factors (putatively associated with cytokine-cytokine receptor interactions) associated with anxiety, depression, and memory problems. Conclusion: While psychiatric symptoms are present during active methamphetamine dependence and remission, at least some cognitive difficulties emerge only during remission. Altered expression of a network of immune factors contributes to neuropsychiatric symptom severity.http://journal.frontiersin.org/Journal/10.3389/fpsyt.2015.00178/fullAnxietyBiological MarkersCognitionCytokinesDepressionInflammation
spellingShingle Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Marilyn eHuckans
Bret E. Fuller
Bret E. Fuller
Alison L. N. Chalker
Madeleine eAdams
Jennifer M. Loftis
Jennifer M. Loftis
Jennifer M. Loftis
Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
Frontiers in Psychiatry
Anxiety
Biological Markers
Cognition
Cytokines
Depression
Inflammation
title Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
title_full Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
title_fullStr Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
title_full_unstemmed Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
title_short Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: An exploratory protein array study
title_sort plasma inflammatory factors are associated with anxiety depression and cognitive problems in adults with and without methamphetamine dependence an exploratory protein array study
topic Anxiety
Biological Markers
Cognition
Cytokines
Depression
Inflammation
url http://journal.frontiersin.org/Journal/10.3389/fpsyt.2015.00178/full
work_keys_str_mv AT marilynehuckans plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT marilynehuckans plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT marilynehuckans plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT marilynehuckans plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT bretefuller plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT bretefuller plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT alisonlnchalker plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT madeleineeadams plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT jennifermloftis plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT jennifermloftis plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy
AT jennifermloftis plasmainflammatoryfactorsareassociatedwithanxietydepressionandcognitiveproblemsinadultswithandwithoutmethamphetaminedependenceanexploratoryproteinarraystudy